Show items per page
Elements: 5
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Risk of recurrent venous thromboembolism according to baseline risk factor profiles Prins, Martin H; Lensing, Anthonie W A; Prandoni, Paolo; Wells, Philip S; ... Weitz, Jeffrey I 2018
add to browser selection
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Weitz, Jeffrey I; Lensing, Anthonie W A; Prins, Martin H; Bauersachs, Rupert; ... Prandoni, Paolo 2017
add to browser selection
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension Wells, Philip S; Prins, Martin H; Levitan, Bennett; Beyer-Westendorf, Jan; ... Lensing, Anthonie W A 2016
add to browser selection
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies Prins, Martin H; Lensing, Anthonie Wa; Bauersachs, Rupert; van Bellen, Bonno; ... Wells, Philip S 2013
add to browser selection
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism Büller, Harry R; Prins, Martin H; Lensing, Anthonie W A; Decousus, Hervé; ... Segers, Annelise 2012